Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Hypoglycemic Activity and Safety Assessment of Pediococcus acidilactici Strain DNH16 in Experimental Type 2 Diabetes Mellitus Rats Induced with Streptozotocin

The Indonesian Biomedical Journal · Vol. 16 No. 1 (2024) · hlm. 31–39

DOI
10.18585/inabj.v16i1.2781
ISSN
2085-3297, 2355-9179
Terbit
2024-02-23
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Type 2 diabetes mellitus (T2DM) cases tend to rise throughout the year in all parts of the world. The α-glucosidase inhibitors are frequently used to both prevent and treat T2DM. This α-glucosidase inhibitor activity is seen in some probiotic species, and a certain strain of Pediococcus acidilactici exhibits promising characteristics as an α-glucosidase inhibitor. This study was conducted to assess the hypoglycemic activity and safety of P. acidilactici strain DNH16 (PADNH16) in experimental rats with T2DM induced by streptozotocin.METHODS: The experiment was conducted in vivo using Wistar rats. Acarbose was employed as a positive control, and Lactobacillus casei was used as a comparative. For 24 days, post-prandial blood glucose levels were assessed every 3 days, followed by serum biochemical levels measurement of liver, kidney, and lipid profiles. The pancreas was histopathologically examined utilizing the Hematoxyline-Eosin staining procedure.RESULTS: Administration of PADNH16 to T2DM rats lowered post-prandial blood glucose levels and gave hypoglycemic benefits comparable to acarbose and commercial probiotics. PADNH16 dosing did not affect serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), urea, or creatinine levels, showing that PADNH16 was not hazardous to liver or kidney function. The lipid profile assessment revealed that the values, including high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides, were comparable to the control group. The pancreatic histopathology revealed that injection of PADNH16 caused no alterations to pancreatic β cells.CONCLUSION: P. acidilactici isolate DNH16 has a hypoglycemic effect on T2DM rats, but does not affect liver function enzymes, kidneys, lipid profiles and does not provide significant changes in pancreatic β cells.KEYWORDS: diabetes mellitus, inhibitor α-glucosidase, Pediococcus acidilactici strain DNH16

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 141 tautan kepenulisan bersama · 24 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Prima Indonesia
  • Universitas Sumatera Utara
  • State University of Semarang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
I Nyoman Ehrich ListerUniversitas Prima Indonesia2
Putranto ManaluUniversitas Prima Indonesia2
Frans Judea SamosirUniversitas Prima Indonesia2
Victor Trismanjaya HuluUniversitas Prima Indonesia2
Santy Deasy SiregarUniversitas Prima Indonesia2
Masryna SiagianUniversitas Prima Indonesia2
Ermi GirsangUniversitas Prima Indonesia2
Maya Sari MutiaUniversitas Prima Indonesia2
Yelvreza Rastiani SipayungUniversitas Prima Indonesia2
Dwi ElmiamUniversitas Prima Indonesia2
Hafiz Hawari SiregarAfiliasi tidak diketahui1
Agnes Novica Putri SilabanAfiliasi tidak diketahui1
Maria SofiyanaAfiliasi tidak diketahui1
Rosi Krisdayanti PurbaAfiliasi tidak diketahui1
Yayo IntisariAfiliasi tidak diketahui1
Pivi NabilaAfiliasi tidak diketahui1
Al-Annisa Fadhila AinyAfiliasi tidak diketahui1
N TariganAfiliasi tidak diketahui1
Ahmad Hasanuddin HasibuanAfiliasi tidak diketahui1
Adek AmansyahUniversitas Prima Indonesia1
Chrismis Novalinda GintingUniversitas Prima Indonesia1
Nyoman Ehrich ListerUniversitas Prima Indonesia1
Hartono HartonoState University of Semarang1
Buenita BuenitaUniversitas Prima Indonesia1
Emira Nadiah HarahapUniversitas Prima Indonesia1
. HartonoState University of Semarang1
Rapael GintingUniversitas Prima Indonesia1
Victorwan Novri ZendratoUniversitas Prima Indonesia1
Lokot Donna LubisUniversitas Sumatera Utara1
Tri WidyawatiUniversitas Sumatera Utara1
Sunarti SunartiUniversitas Prima Indonesia1
Urip HarahapUniversitas Sumatera Utara1
Delyuzar DelyuzarUniversitas Sumatera Utara1
Sri Lestari Ramadhani NasutionUniversitas Prima Indonesia1
Tamarin TamarinUniversitas Prima Indonesia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Hypoglycemic Activity and Safety Assessment of Pediococcus acidilactici Strain DNH16 in Experimental Type 2 Diabetes Mellitus Rats Induced with Streptozotocin</dc:title><dc:creator>Edy Fachrial</dc:creator><dc:creator>Juliana Lina</dc:creator><dc:creator>Harmileni Harmileni</dc:creator><dc:creator>Sari Anggraini</dc:creator><dc:creator>Widya Yanti Sihotang</dc:creator><dc:subject>Pediococcus acidilactici</dc:subject><dc:subject>type 2 diabetes</dc:subject><dc:subject>hypoglycemic activity</dc:subject><dc:subject>α-glucosidase inhibition</dc:subject><dc:subject>probiotics</dc:subject><dc:subject>streptozotocin-induced diabetes</dc:subject><dc:subject>postprandial blood glucose</dc:subject><dc:subject>liver function</dc:subject><dc:subject>renal function</dc:subject><dc:subject>lipid profile</dc:subject><dc:subject>pancreatic beta cells</dc:subject><dc:subject>acarbose</dc:subject><dc:subject>Lactobacillus casei</dc:subject><dc:description xml:lang="en">BACKGROUND: Type 2 diabetes mellitus (T2DM) cases tend to rise throughout the year in all parts of the world. The α-glucosidase inhibitors are frequently used to both prevent and treat T2DM. This α-glucosidase inhibitor activity is seen in some probiotic species, and a certain strain of Pediococcus acidilactici exhibits promising characteristics as an α-glucosidase inhibitor. This study was conducted to assess the hypoglycemic activity and safety of P. acidilactici strain DNH16 (PADNH16) in experimental rats with T2DM induced by streptozotocin.METHODS: The experiment was conducted in vivo using Wistar rats. Acarbose was employed as a positive control, and Lactobacillus casei was used as a comparative. For 24 days, post-prandial blood glucose levels were assessed every 3 days, followed by serum biochemical levels measurement of liver, kidney, and lipid profiles. The pancreas was histopathologically examined utilizing the Hematoxyline-Eosin staining procedure.RESULTS: Administration of PADNH16 to T2DM rats lowered post-prandial blood glucose levels and gave hypoglycemic benefits comparable to acarbose and commercial probiotics. PADNH16 dosing did not affect serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), urea, or creatinine levels, showing that PADNH16 was not hazardous to liver or kidney function. The lipid profile assessment revealed that the values, including high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides, were comparable to the control group. The pancreatic histopathology revealed that injection of PADNH16 caused no alterations to pancreatic β cells.CONCLUSION: P. acidilactici isolate DNH16 has a hypoglycemic effect on T2DM rats, but does not affect liver function enzymes, kidneys, lipid profiles and does not provide significant changes in pancreatic β cells.KEYWORDS: diabetes mellitus, inhibitor α-glucosidase, Pediococcus acidilactici strain DNH16</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-02-23</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v16i1.2781</dc:identifier><dc:identifier>10.18585/inabj.v16i1.2781</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 1 (2024); 31-39</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2781/686</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>